ProCE Banner Series

Prostate Cancer Master Class: Addressing Challenges in A New Era of Personalized Care

Join us in-person in Chicago or via simulcast for this live, interactive Master Class symposium featuring expert-led presentations and small group patient case discussions on the optimal management of prostate cancer. Experts will discuss individualizing treatment for HSPC, whether locally advanced or metastatic, and CRPC to optimize care for patients with prostate cancer.

To Register: Please click the green “Learn More” button below. On the next page, select either Register for In-Person Event or Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

For more information on ASCO’s vaccination and mask requirements, please visit: ASCO’s website.

Not an official event of the 2023 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, CancerLinQ®, or Conquer Cancer®, the ASCO Foundation.

  AMA
Who Should Attend

This educational program is intended for medical oncologists and other healthcare professionals who treat patients with prostate cancer.

All Events

Prostate Cancer Master Class: Addressing Challenges in A New Era of Personalized Care

Past Events

June

04

2023

7:00 PM - 9:00 PM Central Time (CT)

In-personVirtual

Hilton Chicago, 720 South Michigan Avenue, Chicago, Illinois 60604

Topics

Registration & Dinner: 6:30 – 7:00 PM CT

Symposium: 7:00-9:00 PM CT

  • Contemporary Diagnostic Evaluation of Prostate Cancer: Role of Biomarker Testing and Imaging
  • Optimizing, Individualized Treatment for HSPC
  • Master Class Interactive Case Discussions
  • PARP Inhibitors Alone or With Secondary Hormonal Therapies for Patients with mCRPC
  • Master Class Interactive Case Discussions
  • Current and Future Role of PSMA Targeted Therapies for Patients with mCRPC
  • Master Class Interactive Case Discussions
  • New Data and Emerging Agents for Prostate Cancer: Focus on Highlights From ASCO 2023
  • Final Thoughts, and Audience Q & A Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Program Overview
The goal of this activity is to improve the knowledge, confidence, and competence of learners on recognizing and managing the emerging challenges to individualize therapy for patients with prostate cancer.

Target Audience
This educational program is intended for medical oncologists and other healthcare professionals who treat patients with prostate cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply expert recommendations for testing for clinically relevant biomarkers and using advanced molecular imaging to guide treatment strategies in patients with prostate cancer
  • Plan optimal individualized therapeutic strategies for nonmetastatic or metastatic hormone-sensitive prostate cancer (HSPC), considering available agents, clinical data, and expert recommendations, and individual patient needs and preferences
  • Employ an evidence-based approach to the selection and sequencing of available options for patients with mCRPC (including the use of PARP inhibitors alone or with secondary hormonal therapies and the PSMA-targeted radioligand therapy for progressive PSMA-positive mCRPC)
  • Proactively mitigate and manage treatment-related AEs in patients receiving novel therapies and combinations for advanced prostate cancer

Accreditation

Joint Accreditation Statement

A picture containing shapeDescription automatically generated

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck Sharp & Dohme Corp., and Novartis Pharmaceuticals Corporation.